[Glomerular filtration rate is an indicator of endothelial function at early stages of chronic kidney disease]
Related Experiment Video
Updated: Jul 13, 2026

Physiology Lab Demonstration: Glomerular Filtration Rate in a Rat
Published on: July 26, 2015
Insights
Reduced kidney function (GFR) accelerates atherosclerosis in early chronic kidney disease (CKD) patients. This reduction is an independent risk factor, worsening endothelial dysfunction and increasing cardiovascular risk.
Area of Science:
- Nephrology
- Cardiology
- Vascular Biology
Background:
- Early-stage chronic kidney disease (CKD) involves reduced glomerular filtration rate (GFR).
- Endothelial dysfunction is a key factor in cardiovascular complications.
- CKD patients often present with multiple cardiovascular risk factors.
Purpose of the Study:
- To investigate the impact of declining GFR on endothelial function in early-stage CKD.
- To identify GFR reduction as an independent risk factor for atherosclerosis in CKD.
Main Methods:
- Assessed endothelial function in 101 CKD patients (Stage I-III) using reactive hyperemia tests and dopplerography.
- Measured skin vessel responses to iontophoresis of acetylcholine and nitroglycerin.
- Analyzed lipidogram, homocysteine, annexin A5 levels, common carotid artery intima-media thickness, and echocardiography.
Main Results:
- All patients exhibited cardiovascular risk factors, including hypertension, dyslipoproteinemia, and hyperhomocysteinemia.
- Reduced GFR (below 90 ml/min) was identified as an independent risk factor for atherosclerosis.
- Increased body mass index was prevalent among the study participants.
Conclusions:
- GFR reduction in Stage II CKD is linked to increased apoptosis and endothelial vasomotor dysfunction.
- These changes, combined with existing risk factors, contribute to preclinical atherosclerosis.
- Early GFR decline significantly impacts vascular health in CKD patients.
Aim:
To study effects of glomerular filtration rate (GFR) reduction on endothelial function in patients at early stages of chronic renal kidney (CKD).
Material And Methods:
Endothelial function of 101 patients with CKD of stage I-III was examined using reactive hyperemia test, dopplerography of skin vessels with ionophoresis of acetylcholin and nitroglycerin, lipidogram parameters, homocistein and annexin A5 levels, intima-media complex thickness of the common carotid artery, echocardiography findings.
Results:
Cardiovascular complications risk factors were found in all the patients: increased body mass index, arterial hypertension, dyslipoproteinemia, hyperhomocysteinemia. Reduced GFR (under 90 ml/min) is an independent factor of atherosclerosis risk.
Conclusion:
GFR reduction corresponding to CRD of stage II is accompanied with enhancement of apoptosis and development of vasomotor endothelial dysfunction that in combination with risk factors contribute to development of a preclinical atherosclerosis phase.
Related Concept Videos
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Glomerular Filtration Rate and its Regulation
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
Renal Drug Excretion: Glomerular Filtration
Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent arterioles.
Renal Clearance
Renal clearance refers to the volume of plasma cleared of a specific substance, such as creatinine, per unit of time. To measure clearance, urine samples are collected over a 24-hour period during each bladder voiding, followed by a single blood sample at the...
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...

